Scientists have uncovered that chrysin, a natural flavonoid, can attenuate therapy-induced senescence in breast cancer via modulation of the cGAS–STING signaling pathway. Published in Medical Oncology, this finding addresses challenges posed by senescence-associated therapy resistance, opening avenues for combinational cancer treatments that reduce adverse outcomes and improve efficacy.